Publications by authors named "S J Grenfell"

Purpose: Up to 90% of people with Parkinson's disease (PD) develop communication difficulties over the course of the disease. While the negative effect of dysarthria on communicative participation has been well-documented, the impact of the occurrence of acquired stuttered disfluencies on communication in different speech situations is unknown. This study aimed to determine if the frequency of occurrence of stuttered disfluencies affects communicative participation in individuals with PD, and whether such a relationship is mediated by examiner- and self-rated measures of disease severity.

View Article and Find Full Text PDF

Introduction: Recent work suggests that amyloid beta (Aβ) positron emission tomography (PET) tracer uptake shortly after injection ("early phase") reflects brain metabolism and perfusion. We assessed this modality in a predominantly amyloid-negative neurodegenerative condition, Parkinson's disease (PD), and hypothesized that early-phase F-florbetaben (eFBB) uptake would reproduce characteristic hypometabolism and hypoperfusion patterns associated with cognitive decline in PD.

Methods: One hundred fifteen PD patients across the spectrum of cognitive impairment underwent dual-phase Aβ PET, structural and arterial spin labeling (ASL) magnetic resonance imaging (MRI), and neuropsychological assessments.

View Article and Find Full Text PDF
Article Synopsis
  • The New Zealand Parkinson's Progression Programme (NZP3) has studied 354 Parkinson's patients and 89 healthy older individuals over 14 years, focusing on cognitive impairment and identifying future biomarkers.
  • The program has contributed to understanding mild cognitive impairment (MCI) in Parkinson's and validated criteria for its diagnosis, using brain imaging and various biomarker investigations.
  • It has supported other research areas related to Parkinson's, resulting in numerous publications and the training of early-career to senior researchers, while outlining future directions for continued research.
View Article and Find Full Text PDF

Parkinson’s disease affects millions worldwide with a large rise in expected burden over the coming decades. More easily accessible tools and techniques to diagnose and monitor Parkinson’s disease can improve the quality of life of patients. With the advent of new wearable technologies such as smart rings and watches, this is within reach.

View Article and Find Full Text PDF